Loading
Latest filing published 13 Aug 2025 for BioGaia AB, €15k. Read the official filing
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
This profile gathers the share dealings of Theresa Puleo Agnew in BioGaia AB, where the filings describe the role as chief executive. The record holds 2 filings, for trades running from 10 March 2025 to 11 August 2025.
No open-market sale appears; the market trades are 1 purchase worth €15k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 1 share grant.
On 13 August 2025 came the latest disclosure, an open-market purchase for €15k in BioGaia AB. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations